183 related articles for article (PubMed ID: 3919156)
21. Brain ceramide hexosides in Tay-Sachs disease and generalized gangliosidosis (GM1-gangliosidosis).
Suzuki K; Chen GC
J Lipid Res; 1967 Mar; 8(2):105-13. PubMed ID: 14564716
[TBL] [Abstract][Full Text] [Related]
22. Patterns of complex carbohydrate storage in four lysosomal storage diseases: fucosidosis, GM1-gangliosidosis, GM2-gangliosidosis (Sandhoff variant) and mannosidosis.
Dawson G; Chen Tsay G
Biochem Exp Biol; 1977; 13(1):15-25. PubMed ID: 418790
[No Abstract] [Full Text] [Related]
23. Large alterations in ganglioside and neutral glycosphingolipid patterns in brains from cases with infantile neuronal ceroid lipofuscinosis/polyunsaturated fatty acid lipidosis.
Svennerholm L; Fredman P; Jungbjer B; Månsson JE; Rynmark BM; Boström K; Hagberg B; Norén L; Santavuori P
J Neurochem; 1987 Dec; 49(6):1772-83. PubMed ID: 3681296
[TBL] [Abstract][Full Text] [Related]
24. Sialidase NEU3 action on GM1 ganglioside is neuroprotective in GM1 gangliosidosis.
Allende ML; Lee YT; Byrnes C; Li C; Tuymetova G; Bakir JY; Nicoli ER; James VK; Brodbelt JS; Tifft CJ; Proia RL
J Lipid Res; 2023 Dec; 64(12):100463. PubMed ID: 37871851
[TBL] [Abstract][Full Text] [Related]
25. Galactosylceramide- and lactosylceramide-loading studies in cultured fibroblasts from normal individuals and patients with globoid cell leukodystrophy (Krabbe's disease) and GM1-gangliosidosis.
Kobayashi T; Shinnoh N; Goto I; Kuroiwa Y; Okawauchi M; Sugihara G; Tanaka M
Biochim Biophys Acta; 1985 Jul; 835(3):456-64. PubMed ID: 3926002
[TBL] [Abstract][Full Text] [Related]
26. Application of a GM1 ganglioside beta-galactosidase microassay method to diagnosis of GM1 gangliosidosis.
Mutoh T; Kiuchi K; Sobue I; Naoi M
Clin Chim Acta; 1984 Jul; 140(3):223-30. PubMed ID: 6432371
[TBL] [Abstract][Full Text] [Related]
27. Glycosphingolipids of rat T cells. Predominance of asialo-GM1 and GD1c.
Nohara K; Nakauchi H; Spiegel S
Biochemistry; 1994 Apr; 33(15):4661-6. PubMed ID: 8161523
[TBL] [Abstract][Full Text] [Related]
28. Distinct progression patterns of brain disease in infantile and juvenile gangliosidoses: Volumetric quantitative MRI study.
Nestrasil I; Ahmed A; Utz JM; Rudser K; Whitley CB; Jarnes-Utz JR
Mol Genet Metab; 2018 Feb; 123(2):97-104. PubMed ID: 29352662
[TBL] [Abstract][Full Text] [Related]
29. Generalized CNS disease and massive GM1-ganglioside accumulation in mice defective in lysosomal acid beta-galactosidase.
Hahn CN; del Pilar Martin M; Schröder M; Vanier MT; Hara Y; Suzuki K; Suzuki K; d'Azzo A
Hum Mol Genet; 1997 Feb; 6(2):205-11. PubMed ID: 9063740
[TBL] [Abstract][Full Text] [Related]
30. Glycolipid abnormalities in a myoclonic variant of late infantile amaurotic idiocy.
Bartsch GG
J Lipid Res; 1970 May; 11(3):241-7. PubMed ID: 5441250
[TBL] [Abstract][Full Text] [Related]
31. Infantile GM1-gangliosidosis with marked manifestation of lungs.
Matsumoto T; Matsumori H; Taki T; Takagi T; Fukuda Y
Acta Pathol Jpn; 1979 Mar; 29(2):269-76. PubMed ID: 121907
[TBL] [Abstract][Full Text] [Related]
32. Identity of the activator proteins for the enzymatic hydrolysis of sulfatide, ganglioside GM1, and globotriaosylceramide.
Vogel A; Fürst W; Abo-Hashish MA; Lee-Vaupel M; Conzelmann E; Sandhoff K
Arch Biochem Biophys; 1987 Dec; 259(2):627-38. PubMed ID: 3426245
[TBL] [Abstract][Full Text] [Related]
33. GM1-Gangliosidosis: a molecular abnormality of acid beta-galactosidase in fibroblasts.
Furuya T; Suzuki Y
J Inherit Metab Dis; 1984; 7(3):145-6. PubMed ID: 6438402
[No Abstract] [Full Text] [Related]
34. The abnormalities of beta-galactosidase in GM1-gangliosidoses.
Kudoh T
Tohoku J Exp Med; 1978 May; 125(1):93-101. PubMed ID: 27879
[TBL] [Abstract][Full Text] [Related]
35. Properties of a protein activator of glycosphingolipid hydrolysis isolated from the liver of a patient with GM1 gangliosidosis, type 1.
Inui K; Wenger DA
Biochem Biophys Res Commun; 1982 Mar; 105(2):745-51. PubMed ID: 6807306
[No Abstract] [Full Text] [Related]
36. Characterization of a penta-and an octasaccharide from urine of a patient with juvenile GM1-gangliosidosis.
Lunblad A; Sjöblad S; Svensson S
Arch Biochem Biophys; 1978 May; 188(1):130-6. PubMed ID: 98112
[No Abstract] [Full Text] [Related]
37. Characterization of a novel brain neutral glycosphingolipid composition in house musk shrew (Suncus murinus).
Watanabe K; Nishiyama M
Eur J Biochem; 1995 Jun; 230(3):971-6. PubMed ID: 7601161
[TBL] [Abstract][Full Text] [Related]
38. Specific binding of Burkholderia pseudomallei cells and their cell-surface acid phosphatase to gangliotetraosylceramide (asialo GM1) and gangliotriaosylceramide (asialo GM2).
Kanai K; Suzuki Y; Kondo E; Maejima Y; Miyamoto D; Suzuki T; Kurata T
Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):781-90. PubMed ID: 9656402
[TBL] [Abstract][Full Text] [Related]
39. Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains.
Ngamukote S; Yanagisawa M; Ariga T; Ando S; Yu RK
J Neurochem; 2007 Dec; 103(6):2327-41. PubMed ID: 17883393
[TBL] [Abstract][Full Text] [Related]
40. Pseudomonas aeruginosa and Pseudomonas cepacia isolated from cystic fibrosis patients bind specifically to gangliotetraosylceramide (asialo GM1) and gangliotriaosylceramide (asialo GM2).
Krivan HC; Ginsburg V; Roberts DD
Arch Biochem Biophys; 1988 Jan; 260(1):493-6. PubMed ID: 3124753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
